The US Congress is making efforts to reconcile the differences between the House and Senate healthcare reform bills, both of which contain numerous provisions of interest to device manufacturers, such as an annual fee that would cost the industry billions of dollars over the next several years...
Scrip Regulatory Affairs
US medtech industry lobbies to postpone device tax until 2013
12 January 2010
Vibha Sharma
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- White House warns US FDA budget cuts would severely limit agency
- France votes for more regulatory transparency, tighter safety monitoring and tougher promotion controls
- US Senate Judiciary Committee approves bill to limit pay-for-delay settlements
- US House adopts patent reform, but fee change could be trouble for Senate
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
